drugset / Trial / NCT07264543
Early Methylene Blue in the Microhemodynamics of Septic Patients
Phase 2/3
Recruiting
50 enrolled
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
Irmandade da Santa Casa de Misericordia de Curitiba · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the study is to evaluate the viability and feasibility of its protocol in order to conduct a larger clinical trial to assess whether methylene blue can improve patient-centered clinical outcomes such as mortality or length of hospital stay in septic shock patients.
Timeline
- Start
- 2026-01-09
- Primary completion
- 2026-11-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 100 mg | — |